Skip to content
healthcare.dev

Alfuzosin Hydrochloride

NDC 60505-2850, Alfuzosin Hydrochloride, tablet, extended release, from Apotex Corp..

Product NDC
60505-2850
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA079013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2850 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALFUZOSIN HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
60505-2850-96050528500990 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-2850-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/26fcc267-c8d7-e059-1bcf-830dded43690
  • NADAC price for package 60505285009

    GET /v1/drugs/nadac/60505285009

Use it

Look up 60505-2850 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2850 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-2850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.